Inventor
Elisabetta Bianchi
Inventor
Pomezia, IT
Overview
Patents· 17 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides32%
A61KPreparations for medical, dental or toiletry purposes28%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations26%
C12NMicroorganisms or enzymes4%
G01NInvestigating or analysing materials by determining their chemical or physical properties4%
Y02ATechnologies for adaptation to climate change4%
C07CAcyclic or carbocyclic compounds2%
PatentTitleYear
10,988,523Modified lipidated Relaxin B chain peptides and their therapeutic use202110,988,524Modified relaxin B chain peptides and their therapeutic use202110,961,295Modified lipidated Relaxin B chain peptides and their therapeutic use202110,800,826Antibody peptide conjugates that have agonist activity at both the glucagon and glucagon-like peptide 1 receptors202010,793,615Long-acting co-agonists of the glucagon and GLP-1 receptors202010,493,125Co-agonists of the glucagon and GLP-1 receptors201910,413,593Co-agonists of the glucagon and GLP-1 receptors20199,593,155'Oxyntomodulin analogs'20178,969,294'Glucagon/GLP-1 receptor co-agonists'20158,629,101'Cholesterol derivatives of inhibitors of viral fusion'20148,268,779'Pharmaceutical composition comprising oxyntomodulin derivatives and a method for reducing body weight using the composition'20127,928,058'Pharmaceutical composition comprising oxyntomodulin derivatives and a method for reducing body weight using the composition'20117,811,577'Covalently stabilized chimeric coiled-coil HIV gp41 N-peptides with improved antiviral activity'20107,744,887'Human antibodies interacting with HIV gp41'20106,995,177'HCV NS3 protease inhibitors'20066,197,536'Methodology to produce, and purify and assay polypeptides with the proteolytic activity of the HCV NS3 protease'20015,196,512'Synthetic peptides useful as universal carriers for the preparation of immunogenic conjugates and their use in the development of synthetic vaccines'1993Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1993–2014Based in Rome, IT· patent location history
2001–2014Patents assigned to ANGELETTI P IST RICHERCHE BIO (5)· patent assignee history
2010–2020Patents assigned to MERCK SHARP & DOHME (8)· patent assignee history
2010Based in Via Sabotino, IT· patent location history
2012–2020Patents assigned to BIANCHI ELISABETTA (5)· patent assignee history
2012–2020Patents assigned to PESSI ANTONELLO (5)· patent assignee history
2015–2021Based in Pomezia, IT· patent location history
2017Based in Pommezia, IT· patent location history
2021Patents assigned to SANOFI SA (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MERCK SHARP & DOHME | 8 | 2010–2020 |
| ANGELETTI P IST RICHERCHE BIO | 5 | 2001–2014 |
| BIANCHI ELISABETTAself | 5 | 2012–2020 |
| PESSI ANTONELLO | 5 | 2012–2020 |
| SANOFI SA | 3 | 2021 |
Locations
| Location | Patents | Span |
|---|---|---|
| Pomezia, IT | 8 | 2015–2021 |
| Rome, IT | 7 | 1993–2014 |
| Pommezia, IT | 1 | 2017 |
| Via Sabotino, IT | 1 | 2010 |